WEDNESDAY, Sept. 13, 2023 (HealthDay News) — A large number of drugs used to treat everything from multiple sclerosis to blood cancers to rheumatoid arthritis may cause a rare but often-fatal condition called progressive multifocal leukoencephalopathy (PML). But a simple genetic test can determine who has a 10-fold higher riskContinue Reading

TUESDAY, Sept. 5, 2023 (HealthDay News) — Smoking may not only harm the smoker and those who breathe in the secondhand fumes, but also their future children. New research suggests that boys who smoke in their early teens risk passing on harmful genetic traits to future children. The study probedContinue Reading

THURSDAY, Aug. 31, 2023 (HealthDay News) — As it stands, no one blood test or brain scan can definitively diagnose Parkinson’s disease. But researchers report this may soon change if a new blood test continues to show promise. The test measures DNA damage in the mitochondria of cells, which isContinue Reading

WEDNESDAY, Aug. 2, 2023 (HealthDay News) — A newly discovered genetic variant might explain why some people of African ancestry have naturally lower viral loads of HIV, an international team of researchers reports. This variant, carried by an estimated 4% to 13% of people of African origin, reduces their riskContinue Reading

WEDNESDAY, July 19, 2023 (HealthDay News) — In the world of COVID-19 infections, the majority of patients develop symptoms, while about one-fifth mysteriously don’t develop a cough, sore throat or other tell-tale signs of illness. Now, new research finds that these symptom-free super-dodgers are more than twice as likely asContinue Reading

TUESDAY, July 11, 2023 (HealthDay News) — Identifying genetic disorders in newborns and infants can help them get the care they need, but one approach — whole genome sequencing — appears far superior to another. In a new study, researchers compared whole genome sequencing with targeted gene-sequencing. They found thatContinue Reading

FRIDAY, June 23, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Thursday approved the drug Elevidys, the first gene therapy for the treatment of children with Duchenne muscular dystrophy (DMD). The groundbreaking treatment will not be cheap: Drugmaker Sarepta Therapeutics Inc. said it would charge $3.2 millionContinue Reading